Genus plc
| File:Genus logo.png | |
| Company type | Public |
|---|---|
| LSE: GNS | |
| ISIN | GB0002074580  |
| Industry | Biotechnology |
| Founded | 1933 |
| Headquarters | Basingstoke, Hampshire, UK |
Key people | Bob Lawson, Chairman[1] Karim Bitar, CEO[1] |
| Revenue | £398.5 million (2015)[2] |
| £59.5 million (2015)[2] | |
| £40.5 million (2015)[2] | |
| Website | www |
Genus plc is a British-based business selling products manufactured using biotechnology to cattle and pig farmers. It is headquartered in Basingstoke and is a constituent of the FTSE 250 Index.
History
The business has its origins in the former Breeding & Production Division of the Milk Marketing Board which was established in 1933 and broken up in 1994.[3] In 1999 Genus acquired ABS Global, a company founded by J.R. Prentice in the US as the American Breeders Service in 1941 selling the semen of cattle.[4] In 2005 Genus acquired, through the takeover of Sygen International plc, PIC, a company founded by six pork producers in the UK as the Pig Improvement Company in 1962.[5]
Board of Directors
- Bob Lawson (Chairman)[1]
- Karim Bitar (CEO)
- Stephen Wilson (Group Finance Director)
- Nigel Turner (Senior Non-Executive Director)
- Mike Buzzacott (Non-Executive Director)
- Professor Duncan Maskell (Non-Executive Director)
- Lykele van der Broek (Non-Executive Director)
- Dan Hartley (Group General Counsel & Company Secretary)
Operations
The Company has two divisions:
References
- ^ a b c "Genus plc - Investor Relations - Genus Board". genusplc.com. Retrieved 28 March 2015.
- ^ a b c "Preliminary Results 2015". Genus plc. Retrieved 9 April 2016.
- ^ The BSE Inquiry
- ^ ABS Global Parent Reports Positive Year-End Results and Stock Listing
- ^ "Genus Completes Acquisition Of Sygen". The Pig Site. Retrieved 28 March 2015.
External links
| Companies |
| ||||
|---|---|---|---|---|---|
| Government and regulatory bodies |
| ||||
| Industry and professional bodies |
| ||||
| Books and journals | |||||
| Other | |||||
